Psychopharmacology and Psychiatry Updates
Un pódcast de Psychopharmacology Institute
Categorías:
213 Episodo
-
Balancing Benefits and Risks: Antipsychotics in Hepatic Dysfunction
Publicado: 25/6/2024 -
Insomnia and Depression: A Tangled Web
Publicado: 20/6/2024 -
ADHD Treatment During Pregnancy: Insights from Denmark
Publicado: 15/6/2024 -
The Power of Nonpharmacologic Therapies in Fibromyalgia
Publicado: 10/6/2024 -
Highlights From APA 2024: Key Insights on Psychopharmacology
Publicado: 5/6/2024 -
Antidepressants in Pregnancy: Weighing the Evidence
Publicado: 31/5/2024 -
Unraveling the Pharmacological Puzzle of Fibromyalgia
Publicado: 26/5/2024 -
Weighing the Evidence: Antipsychotics in Pediatric Anorexia Nervosa
Publicado: 21/5/2024 -
Beyond the Pain: Diagnosing Fibromyalgia
Publicado: 17/5/2024 -
Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects
Publicado: 11/5/2024 -
Mastering Clozapine: Adverse Effect Management
Publicado: 6/5/2024 -
Preventing Depression and Anxiety Relapse in Youth
Publicado: 1/5/2024 -
Charting the Clozapine Course: Titration and Monitoring
Publicado: 26/4/2024 -
Smoking and Psychosis: Insights from the PATH Study
Publicado: 21/4/2024 -
Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia
Publicado: 16/4/2024 -
Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry
Publicado: 11/4/2024 -
Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice
Publicado: 6/4/2024 -
Zuranolone: A New Dawn for Postpartum Depression Treatment
Publicado: 1/4/2024 -
Micronutrients for Psychiatric Disorders: Optimizing Clinical Use
Publicado: 27/3/2024 -
Olanzapine in Pregnancy: Examining the Risks
Publicado: 22/3/2024
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.